CRUN

Home

PRESS RELEASE

Professor Halidou Tinto Winner of Nature’10 which rewards the ten scientific personalities who marked the year 2023 in the world. Scroll down for more information.

VAC091 Vaccine Started on April 12,2023

A Phase IIb randomised controlled trial of the safety, immunogenicity and efficacy of the blood-stage malaria vaccine candidates RH5.1 in Matrix-MTM and RH5.2-VLP in Matrix-MTM in infants aged 5-17 months in Burkina Faso.

Research

We are involved in the Health Research Venture

Clinical Research

We are at the forefront of drugs and vaccines trials in Africa

Data

We generate data to improve human health

Laboratory-pana1

Our Laboratories

Our global laboratories can provide diagnostics solutions for clinical trials across Africa and the world.

Projections-cuate1

Our Projects

CRUN performs study and teach in a variety of areas, including policy, epidemiology, behavioral science, diagnostics and pharmaceutical development, clinical trials, and bench science.

Collab-pana1

Our Teams

With specialist research groups research at CRUN focuses on structural biology, molecular cell biology and more.

vector-smart-object-2.png
Projections-cuate1
vector-smart-object-1.png
11103318
DD days
HH hours
MM min

Latest News

Latest Activies

We currently have no job openings

CRUN  is not recruiting for the moment